Insider Buying: Beyond Air, Inc. (NASDAQ:XAIR) Director Buys 20,000 Shares of Stock

Beyond Air, Inc. (NASDAQ:XAIRGet Rating) Director Robert Carey bought 20,000 shares of the firm’s stock in a transaction that occurred on Friday, November 18th. The stock was purchased at an average cost of $5.80 per share, with a total value of $116,000.00. Following the completion of the purchase, the director now directly owns 792,323 shares of the company’s stock, valued at approximately $4,595,473.40. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Robert Carey also recently made the following trade(s):

  • On Wednesday, November 16th, Robert Carey acquired 10,000 shares of Beyond Air stock. The shares were bought at an average cost of $6.00 per share, with a total value of $60,000.00.

Beyond Air Price Performance

XAIR stock opened at $5.81 on Monday. The company has a fifty day moving average price of $7.26 and a two-hundred day moving average price of $7.63. Beyond Air, Inc. has a one year low of $4.78 and a one year high of $16.41. The stock has a market cap of $173.78 million, a price-to-earnings ratio of -3.25 and a beta of -0.12.

Beyond Air (NASDAQ:XAIRGet Rating) last released its quarterly earnings data on Tuesday, November 8th. The company reported ($0.40) EPS for the quarter, missing analysts’ consensus estimates of ($0.36) by ($0.04). Research analysts anticipate that Beyond Air, Inc. will post -1.52 EPS for the current fiscal year.

Hedge Funds Weigh In On Beyond Air

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Vanguard Group Inc. boosted its position in Beyond Air by 0.9% during the third quarter. Vanguard Group Inc. now owns 1,131,763 shares of the company’s stock worth $8,420,000 after purchasing an additional 9,617 shares during the period. Gendell Jeffrey L lifted its holdings in shares of Beyond Air by 8.1% during the third quarter. Gendell Jeffrey L now owns 704,379 shares of the company’s stock worth $5,241,000 after buying an additional 53,032 shares in the last quarter. Wealth Effects LLC lifted its holdings in shares of Beyond Air by 11.4% during the second quarter. Wealth Effects LLC now owns 327,909 shares of the company’s stock worth $2,194,000 after buying an additional 33,500 shares in the last quarter. BlackRock Inc. lifted its holdings in shares of Beyond Air by 7.5% during the third quarter. BlackRock Inc. now owns 286,128 shares of the company’s stock worth $2,129,000 after buying an additional 19,930 shares in the last quarter. Finally, Renaissance Technologies LLC lifted its holdings in shares of Beyond Air by 123.0% during the first quarter. Renaissance Technologies LLC now owns 152,300 shares of the company’s stock worth $1,017,000 after buying an additional 83,998 shares in the last quarter. 16.45% of the stock is owned by institutional investors.

Beyond Air Company Profile

(Get Rating)

Beyond Air, Inc operates as a commercial medical device and biopharmaceutical company. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment of viral lung infections, such as community-acquired viral pneumonia, including COVID-19, as well as bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria.

Read More

Insider Buying and Selling by Quarter for Beyond Air (NASDAQ:XAIR)

Receive News & Ratings for Beyond Air Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beyond Air and related companies with MarketBeat.com's FREE daily email newsletter.